Regenxbio Inc (RGNX)

R&D Expenses

$229.14M

TTM · Period ending: · USD

RGNX logo

RGNX R&D Expenses

Latest reported$229.14M
RGNX TTM R&D Expenses ($4.96M → $229.14M)
High-resolution chart · PNG

RGNX r&d expenses history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Regenxbio Inc R&D Expenses — Trailing twelve months (TTM) (USD)
Period endingR&D Expenses (USD)
229,137,000
228,646,000
224,394,000
215,163,000
213,491,000
202,714,000
200,291,000
201,257,000
205,011,000
220,079,000
227,931,000
239,090,000
244,220,000
245,342,000
242,453,000
227,926,000
212,468,000
197,342,000
181,437,000
180,639,000
176,752,000
168,981,000
166,294,000
152,921,000
144,645,000
136,017,000
124,185,000
114,707,000
97,523,000
89,526,000
83,873,000
73,714,000
67,724,000
60,155,000
57,224,000
59,113,000
59,155,000
55,918,000
45,482,000
34,235,000
27,339,000
20,671,000
17,279,000
14,559,000
9,980,000
6,818,000
4,964,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.